PTC Therapeutics
Pharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about PTC Therapeutics?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
40.550722°N 74.423071°W / 40.550722; -74.423071
Quick Facts Company type, Traded as ...
Company type | Public |
---|---|
Nasdaq: PTCT Russell 2000 Component | |
Industry | Pharmaceuticals |
Founded | 1 January 1998 |
Headquarters | , United States |
Website | ptcbio |
Close
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
PTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.[1][2]
In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases.[3] PTC acquired the Bio-e platform in 2019.[4]